Unlike CD4+ T-cell help, CD28 costimulation is necessary for effective primary CD8+ T-cell influenza-specific immunity

European Journal of Immunology
Shirley G K SeahAndrew M Lew

Abstract

The importance of costimulation on CD4(+) T cells has been well documented. However, primary CTLs against many infections including influenza can be generated in the absence of CD4(+) T-cell help. The role of costimulation under such "helpless" circumstances is not fully elucidated. Here, we investigated such a role for CD28 using CTLA4Ig transgenic (Tg) mice. To ensure valid comparison across the genotypes, we showed that all mice had similar naïve precursor frequencies and similar peak viral loads. In the absence of help, viral clearance was significantly reduced in CTLA4Ig Tg mice compared with WT mice. CD44(+) BrdU(+) influenza-specific CD8(+) T cells were diminished in CTLA4Ig Tg mice at days 5 and 8 postinfection. Adoptive transfer of ovalbumin-specific transgenic CD8(+) T cells (OT-I)-I cells into WT or CTLA4Ig Tg mice revealed that loss of CD28 costimulation resulted in impairment in OT-I cell division. As shown previously, neither viral clearance nor the generation of influenza-specific CD8(+) T cells was affected by the absence of CD4(+) T cells alone. In contrast, both were markedly impaired by CD28 blockade of "helpless" CD8(+) T cells. We suggest that direct CD28 costimulation of CD8(+) T cells is more critical in ...Continue Reading

References

Sep 1, 1989·Clinical Immunology and Immunopathology·R R GhobrialH Auchincloss
Jul 1, 1993·European Journal of Immunology·H BodmerD Mathis
May 1, 1996·The Journal of Experimental Medicine·P BorrowR A Flavell
Mar 1, 1997·Journal of Virology·C ZimmermannR M Zinkernagel
Jan 7, 1998·Immunological Reviews·P C DohertyP G Stevenson
Aug 6, 1998·European Journal of Immunology·L Tuosto, O Acuto
Aug 26, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P CinqueA Linde
Feb 13, 1999·Science·M L Dustin, A S Shaw
Jun 22, 1999·The Journal of Experimental Medicine·C RuedlM F Bachmann
Dec 22, 1999·The Journal of Immunology : Official Journal of the American Association of Immunologists·J M LumsdenF Ronchese
Feb 9, 2000·The Journal of Experimental Medicine·Z LuD M Pardoll
Feb 29, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·K MozdzanowskaW Gerhard
Mar 22, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·S O AndreasenA R Thomsen
May 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·G DeliyannisA M Lew
Mar 23, 2001·Nature Immunology·A V Gett, P D Hodgkin
Oct 18, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·Y ZhanA M Lew
Sep 7, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·J A WileyA G Harmsen
Nov 8, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·M SureshR Ahmed
Nov 8, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·S E HamiltonJ T Harty
Apr 17, 2002·The Journal of Experimental Medicine·Jian-Xin GaoYang Liu
May 22, 2002·Nature Immunology·E Scott HalsteadPeter D Katsikis
Nov 5, 2002·Journal of Virology·Gabrielle T BelzPeter C Doherty
Jan 23, 2003·Proceedings of the National Academy of Sciences of the United States of America·Yifan ZhanAndrew M Lew
Feb 21, 2003·Nature·Edith M JanssenStephen P Schoenberger
Apr 12, 2003·Science·Joseph C Sun, Michael J Bevan
Feb 27, 2004·Immunology and Cell Biology·Georg BehrensWilliam R Heath
Mar 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Joseph C Sun, Michael J Bevan

❮ Previous
Next ❯

Citations

May 28, 2013·Archivum Immunologiae Et Therapiae Experimentalis·K Kai McKinstryTara M Strutt
Jun 1, 2013·Current Opinion in Virology·M L B HillaireJ H C M Kreijtz
May 11, 2013·European Journal of Immunology·Martijn A Nolte, Rene A W van Lier
Jan 21, 2018·Frontiers of Medicine·Simone NüssingKatherine Kedzierska

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.